Page last updated: 2024-10-26

enoxacin and Bronchial Pneumonia

enoxacin has been researched along with Bronchial Pneumonia in 1 studies

Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.

Research Excerpts

ExcerptRelevanceReference
"Enoxacin was administered at the dose of 800 mg twice daily by the oral route."2.66Efficacy and safety of enoxacin in the treatment of respiratory infections. ( Della Torre, F; Fraschini, F; Scaglione, F; Scarpazza, G, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scarpazza, G1
Della Torre, F1
Scaglione, F1
Fraschini, F1

Trials

1 trial available for enoxacin and Bronchial Pneumonia

ArticleYear
Efficacy and safety of enoxacin in the treatment of respiratory infections.
    International journal of clinical pharmacology research, 1989, Volume: 9, Issue:1

    Topics: Adult; Aged; Bronchitis; Bronchopneumonia; Clinical Trials as Topic; Enoxacin; Female; Humans; Male;

1989